In a study by Larson et al. it was reported that only 12.8% of PhD graduates can garner an academic position in the U.S. Meanwhile in the past ten years the number of PhDs in
The biopharma industry has a global market value of $860 billion. If that isn’t significant enough for you, the industry is expected to have a CAGR of 8.7%, meaning the industry will almost double by
With 136,800 job openings projected for each of the next ten years, recovery from a tough 2023 hiring market should be assured. Dawn Fay, President of Robert Half, says, “Competitive pay and flexible work are
“Top talent will always be in demand for the commercial analytics area of the pharmaceutical industry,” says Executive Recruiter Eda Zullo who has specialized in recruiting and placing these candidates for the past 15 years.
R&D in 2023 grew 5.89% with a substantial 21,292 drugs in development from preclinical to launch. This was behind 2022’s 8.22% surge but higher than 2021’s 4.76%. These three years of growth show a steady
In many ways, the economic landscape of 2023 was turbulent. High inflation? Talent shortages? Rising costs of doing business? Volatile currency markets? New regulatory hurdles? Check, check and check. To navigate the choppy waters, a
